Management of Patients with Inflammatory Diseases during the COVID-19 Pandemic

Patients with inflammatory diseases who receive moderate or high-risk anti-inflammatory therapies might be considered as an increased risk group for severe COVID-19 and appropriate measures should be taken in order to protect them. . Initiation of immuno-suppressive/modulatory therapies should be do...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mediterr J Rheumatol
Main Authors: Apostolou, Theofanis, Koutroubakis, Ioannis E., Manolakopoulos, Spilios, Mantzaris, Gerasimos, Rigopoulos, Dimitrios, Triantafyllou, Konstantinos, Vassilopoulos, Dimitrios
Formato: Artigo
Idioma:Inglês
Publicado em: The Mediterranean Journal of Rheumatology (MJR) 2020
Assuntos:
Joint Position Statement
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7656124/
https://ncbi.nlm.nih.gov/pubmed/33196008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.31.3.295
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados